VDAC1 and non-small cell lung carcinoma: As the transformation of NSCLC into SCLC has been reported [80,81,85,86], our results present a treatment involving metabolic reprogramming via VDAC1 depletion, which inhibits the growth of tumors caused by NSCLC, SCLC, or their combination.